Reynders McVeigh Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-34,803
| Closed | -$1.16M | – | 220 |
|
|
2017
Q2 | $1.16M | Sell |
34,803
-27,531
| -44% | -$914K | 0.15% | 88 |
|
|
2017
Q1 | $2M | Sell |
62,334
-65,118
| -51% | -$2.09M | 0.27% | 71 |
|
|
2016
Q4 | $4.62M | Sell |
127,452
-40,826
| -24% | -$1.48M | 0.66% | 41 |
|
|
2016
Q3 | $7.74M | Buy |
168,278
+2,670
| +2% | +$123K | 1.13% | 26 |
|
|
2016
Q2 | $8.32M | Buy |
165,608
+12,758
| +8% | +$641K | 1.21% | 22 |
|
|
2016
Q1 | $8.18M | Sell |
152,850
-2,705
| -2% | -$145K | 1.21% | 22 |
|
|
2015
Q4 | $10.2M | Sell |
155,555
-1,365
| -0.9% | -$89.6K | 1.67% | 19 |
|
|
2015
Q3 | $8.86M | Sell |
156,920
-3,584
| -2% | -$202K | 1.54% | 22 |
|
|
2015
Q2 | $9.49M | Sell |
160,504
-2,195
| -1% | -$130K | 1.55% | 23 |
|
|
2015
Q1 | $10.1M | Sell |
162,699
-5,171
| -3% | -$322K | 1.74% | 21 |
|
|
2014
Q4 | $9.65M | Sell |
167,870
-646
| -0.4% | -$37.2K | 1.69% | 23 |
|
|
2014
Q3 | $9.06M | Sell |
168,516
-9,935
| -6% | -$534K | 1.72% | 22 |
|
|
2014
Q2 | $9.35M | Sell |
178,451
-15,160
| -8% | -$795K | 2.13% | 14 |
|
|
2014
Q1 | $10.2M | Sell |
193,611
-18,970
| -9% | -$1M | 2.42% | 12 |
|
|
2013
Q4 | $8.52M | Sell |
212,581
-22,485
| -10% | -$901K | 2.11% | 13 |
|
|
2013
Q3 | $8.88M | Sell |
235,066
-3,285
| -1% | -$124K | 2.46% | 10 |
|
|
2013
Q2 | $9.34M | Buy |
+238,351
| New | +$9.34M | 2.77% | 9 |
|